Frederick nucleic acid API manufacturing expansion
Agilent Technologies, Frederick, Weld County, Colorado
Frederick nucleic acid API manufacturing expansion in Frederick, Colorado is Agilent Technologies’ plant for therapeutic oligonucleotide active pharmaceutical ingredients. Status: under construction as of February 16, 2023 (groundbreaking). Agilent Technologies announced $725 million and 160 jobs. Primary source: businesswire.com, checked November 12, 2026.
- Status
- Under construction
- Announced investment
- $725 million
- Announced jobs
- 160
- Industry
- Pharmaceuticals
- Sheet
- CO-03
- Revised
- November 12, 2026
Status timeline
- Groundbreakingbusinesswire.com
Filled dots are confirmed by a company, state, SEC or federal source. Dashed dots come from news reports only. Investment and job figures are as announced, not achieved.
Plant facts
| Company | Agilent Technologies |
|---|---|
| Plant | Frederick nucleic acid API manufacturing expansion |
| Location | Frederick, Weld County, Colorado |
| Industry | Pharmaceuticals |
| Product | Therapeutic oligonucleotide active pharmaceutical ingredients |
| Announced investment | $725 million |
| Announced jobs | 160 |
| Last checked | November 12, 2026 |
Sources
- Agilent breaks ground on $725 million expansion in Frederick (company release, businesswire.com, checked November 12, 2026)
Something changed? Send a correction with a link and we'll recheck it.